FFO
XFOR icon

Fortitude Family Office’s X4 Pharmaceuticals XFOR Stock Holding History

Fortitude Family Office’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-137
Closed -$548 – 2088
2025
Q4 		$548 Buy
+137
New +$498 ﹤0.01% 1673

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Fortitude Family Office's XFOR Position: Q1 2026 in Review

Fortitude Family Office sold out of X4 Pharmaceuticals (XFOR) in Q1 2026, closing a stake of 137 shares — an estimated $548 sold.

Fortitude Family Office first reported a position in XFOR in Q4 2025 and held it in 1 quarter. The position peaked at $548 in Q4 2025. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

  • Fortitude Family Office reported no remaining X4 Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Fortitude Family Office sold 137 X4 Pharmaceuticals shares in Q1 2026, an estimated $548.
  • Fortitude Family Office first reported a position in X4 Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Fortitude Family Office's X4 Pharmaceuticals position peaked at $548 in Q4 2025.
  • 84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.